Consistent with this suggestion, our experiments demonstrate that blockade of NOD2 signals via RIP2 and P38 inhibition using SB203580 attenuated sepsis by reducing C5a generation, suggesting that inhibitors of RIP2 and/or its downstream molecules may be therapeutically useful for treatment of patients with sepsis. The gene discussed is RIPK2; the disease is Sepsis.